RxDoctor Payments Data

Marybeth Hughes, MD

Surgical Oncology · Norfolk, VANPI 1033426150

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.7%), other and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 97.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $3,215 and has fallen 100.0% since, to $1 in 2025.

$10,181in general payments, 2019–2025

Across 31 payments — averaging $328.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$10K
  • Molli Surgical (US) Inc$83
  • Teleflex LLC$44
  • Polynovo North America LLC$34
  • Z-medica, LLC$30
  • Stryker$25
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$1,94519%
  • Food & beverage$4875%
  • Education$4,75047%
  • Other$3,00029%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical24$9,951
Molli Surgical (US) Inc1$83
Teleflex LLC2$44
Polynovo North America LLC1$34
Z-medica, LLC1$30
Stryker1$25
Coopersurgical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,181 in reported general payments places this provider in the 75th percentile of 28 surgical oncology providers in Virginia.

See all surgical oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$142,974
Medicare patients
282
Services billed
662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase14$8,297
Pantoprazole Sodium20$243
Oxycodone Hcl15$27

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →